Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: A comparative study with omeprazole and lansoprazole

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 251-257

  Takeuchi, Koji ^a   Konaka, Akira ^a   Nishijima, Masato ^a   Kato, Shinichi ^a   Yasuhiro, Tetsuya ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acid secretion; Alkaline secretion; Duodenal ulcer; Mepirizole; Pantoprazole

Indexed keywords

ACETIC ACID; ANTIULCER AGENT; EPIRIZOLE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DUODENUM PH; DUODENUM ULCER; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTON TRANSPORT; PYLORUS LIGATION; RAT; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; STOMACH PH; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; ULCER HEALING;

EID: 0032920529     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01843.x     Document Type: Article

References (33)

1. 1 McTavish D, Buckely M, Heel R. Omeprazole: An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991; 42: 138-70.
2. 2 Satoh H, Inatomi N, Nagaya H et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J. Pharmacol. Exp. Ther. 1989; 248: 806-15.
3. 3 Mulder CJ, Schipper DL. Omeprazole and ranitidine in duodenal ulcer healing. Scand. J. Gastroenterol. 1990; 25 (Suppl. 178): 62-6.
4. 4 Takemoto T, Namiki M, Goto Y, Mutsuo Y, Miwa T. A study of clinical usefulness of lansoprazole (AG-1749) in treating gastric ulcer: A comparison with famotidine by multiclinic double-binding technique. Rinsyosheijinbyo 1991; 21: 327-45.
5. 5 Rendic S, Sunjic V, Toso R, Kajtez F, Rut HH. Interaction of cimetidine with liver microsomes. Xenobiotica 1979; 9: 555-64.
6. 6 Wilkinson CF, Hetriarski K, Yellin TO. Imidazole derivatives. A new class of microsomal enzyme inhibitors. Biochem. Pharmacol. 1972; 21: 3187-92.
7. 7 Murray M. Mechanisms of the inhibition of cytochromeP-450-mediated drug oxidation by therapeutic agents. Drug Metab. Rev. 1987; 18: 55-81.
8. 8 Kohl B, Sturm E, Senn-Bilfinger J et al. (H+,K+) -ATPase inhibiting 2-[(2-pyridyl-methyl) sulfinyl]benzimidazoles. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate. J. Med. Chem. 1992; 35: 1049-57.
9. 9 Simon B, Muler P, Marinis E et al. Effect of repeated oral administration of BY1023/SK & F96022 - a new substituted benzimidazole derivative on pentagastrin-stimulated gastric acid secretion and pharmaco-kinetics in man. Aliment. Pharmacol. Ther. 1990; 4: 375-9.
10. 10 Reil L, Erhardt F, Fischer R, Londong W. Intragastric pH and serum gastrin after one week treatment with pantoprazole, ranitidine or placebo in man. Gastroenterology 1993; 104: A177.
11. 11 Hotz J, Plein K, Schonekas H, Rose K. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand. J. Gastroenterol. 1995; 30: 111-15.
12. 12 Schepp W, Classen M. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Scand. J. Gastroenterol. 1995; 30: 511-14.
13. 13 Ekstrom P, Unge P, Ahlberg J et al. Lansoprazole vs omeprazole in active duodenal ulcer - A healing study. Scand. J. Gastroenterol. 1992; 27 (Suppl.): 40.
14. 14 Beker JA, Bianchi Porro G, Bigard MA et al. Double-blind comparison of pantoprazole and omeprazole for treatment of acute duodenal ulcer. Eur. J. Gastroenterol. Hepatol. 1995; 7: 407-10.
15. 15 Gugler R, Hartmann M, Rudi J, Bliesah H, Brod I, Klotz U. Lack of interaction of pantoprazole and diazepam in man. Gastroenterology 1992; 102: A77.
16. 16 De Mey C, Meineke I, Steinijans VW et al. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction. Int. J. Clin. Pharm. Ther 1994; 32: 98-106.
17. 17 Schulz HU, Hartmann M, Steinijans VW et al. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. Int. J. Clin. Pharm. Ther. Tox. 1991; 29: 369-75.
18. 18 Ueshima K, Takeuchi K, Okabe S. Acid secretory duodenal ulcerogenic responses induced by mepirizole in anesthetized rats. Dig. Dis. Sci. 1994; 39: 1625-32.
19. 19 Takeuchi K, Furukawa O, Okabe S. A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Gastroenterology 1986; 90: 636-45.
20. 20 Okabe S, Ishihara Y, Inoo T, Tanaka H. Mepirizole-induced duodenal ulcer in rats and their pathogenesis. Dig. Dis. Sci. 1982; 27: 242-9.
21. 21 Okabe S, Pfiffer C, Ross JA. A method for experimental, penetrating gastric and duodenal ulcers in rats. Am. J. Dig. Dis. 1971; 16: 277-84.
22. 22 Kromer W. Similarities and differences in the properties of substituted benzimidazoles - A comparison between pantoprazole and related compounds. Digestion 1995; 56: 443-54.
23. 23 Rehner M, Rohner HG, Schepp A. Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration: A multicentre study. Aliment Pharmacol. Ther. 1995; 9: 411-16.
24. 2-receptor antagonists. Gastroenterology 1985; 88: 1620.
25. 25 Corinaldesi R, Valentini M, Belahe J, Colin R, Geldof H, Maier C. Pantoprazole and omeprazole in the treatment of reflex oesophagitis: A European multi-centre study. Aliment Pharmacol. Ther. 1995; 9: 667-71.
26. 26 Yamamoto O, Okada M, Okabe S. Effects of a proton pump inhibitor omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig. Dis. Sci. 1984; 29: 394-401.
27. 27 Satoh H, Inatomi N, Nagaya H et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J. Pharmacol. Exp. Ther. 1989; 248: 806-15.
28. 28 Tanaka H, Ueki S, Ohno T, Takeuchi K, Okabe S. Pathogenic mechanisms involved in mepirizole-induced duodenal damage in the rat. Jpn J. Pharmacol. 1986; 42: 383-96.
29. G-nitro-L-arginine methyl ester on duodenal alkaline secretory and ulcerogenic responses induced by mepirizole in rats. Dig. Dis. Sci. 1995; 40: 670-7.
30. 30 Inada I, Satoh H. Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats. Dig. Dis. Sci. 1996; 41: 785-90.
31. 31 Okabe S, Takeuchi K, Nakamura K, Takagi K. Effect of antipeptic and anticholinergic agents on the development and healing of duodenal ulcers in the rat. Digestion 1974; 10: 113-21.
32. 32 Okabe S, Takeuchi K, Urushidani T, Murata T, Takagi K. Effects of cimetidine on healing of chronic gastric and duodenal ulcers in dogs. Am. J. Dig. Dis. 1978; 23: 166-8.
33. 33 Folkman J, Szabo S, Strovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 1991; 214: 414-27.